LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 19

Search options

  1. Article ; Online: Organotypic Hippocampal Slice Cultures from Adult Tauopathy Mice and Theragnostic Evaluation of Nanomaterial Phospho-TAU Antibody-Conjugates.

    Kemppainen, Susanna / Huber, Nadine / Willman, Roosa-Maria / Zamora, Ana / Mäkinen, Petra / Martiskainen, Henna / Takalo, Mari / Haapasalo, Annakaisa / Sobrino, Tomás / González Gómez, Manuel Antonio / Piñeiro, Yolanda / Rivas, José / Himmelreich, Uwe / Hiltunen, Mikko

    Cells

    2023  Volume 12, Issue 10

    Abstract: Organotypic slice culture models surpass conventional in vitro methods in many aspects. They retain all tissue-resident cell types and tissue hierarchy. For studying multifactorial neurodegenerative diseases such as tauopathies, it is crucial to maintain ...

    Abstract Organotypic slice culture models surpass conventional in vitro methods in many aspects. They retain all tissue-resident cell types and tissue hierarchy. For studying multifactorial neurodegenerative diseases such as tauopathies, it is crucial to maintain cellular crosstalk in an accessible model system. Organotypic slice cultures from postnatal tissue are an established research tool, but adult tissue-originating systems are missing, yet necessary, as young tissue-originating systems cannot fully model adult or senescent brains. To establish an adult-originating slice culture system for tauopathy studies, we made hippocampal slice cultures from transgenic 5-month-old hTau.P301S mice. In addition to the comprehensive characterization, we set out to test a novel antibody for hyperphosphorylated TAU (pTAU, B6), with and without a nanomaterial conjugate. Adult hippocampal slices retained intact hippocampal layers, astrocytes, and functional microglia during culturing. The P301S-slice neurons expressed pTAU throughout the granular cell layer and secreted pTAU to the culture medium, whereas the wildtype slices did not. Additionally, cytotoxicity and inflammation-related determinants were increased in the P301S slices. Using fluorescence microscopy, we showed target engagement of the B6 antibody to pTAU-expressing neurons and a subtle but consistent decrease in intracellular pTAU with the B6 treatment. Collectively, this tauopathy slice culture model enables measuring the extracellular and intracellular effects of different mechanistic or therapeutic manipulations on TAU pathology in adult tissue without the hindrance of the blood-brain barrier.
    MeSH term(s) Mice ; Animals ; Tauopathies/metabolism ; Mice, Transgenic ; Neurons/metabolism ; Brain/metabolism ; Hippocampus/metabolism
    Language English
    Publishing date 2023-05-18
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2661518-6
    ISSN 2073-4409 ; 2073-4409
    ISSN (online) 2073-4409
    ISSN 2073-4409
    DOI 10.3390/cells12101422
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: MECP2 Increases the Pro-Inflammatory Response of Microglial Cells and Phosphorylation at Serine 423 Regulates Neuronal Gene Expression upon Neuroinflammation.

    Wittrahm, Rebekka / Takalo, Mari / Marttinen, Mikael / Kuulasmaa, Teemu / Mäkinen, Petra / Kemppainen, Susanna / Martiskainen, Henna / Rauramaa, Tuomas / Pike, Ian / Leinonen, Ville / Natunen, Teemu / Haapasalo, Annakaisa / Hiltunen, Mikko

    Cells

    2021  Volume 10, Issue 4

    Abstract: Methyl-CpG-binding protein 2 (MECP2) is a critical transcriptional regulator for synaptic function. Dysfunction of synapses, as well as microglia-mediated neuroinflammation, represent the earliest pathological events in Alzheimer's disease (AD). Here, ... ...

    Abstract Methyl-CpG-binding protein 2 (MECP2) is a critical transcriptional regulator for synaptic function. Dysfunction of synapses, as well as microglia-mediated neuroinflammation, represent the earliest pathological events in Alzheimer's disease (AD). Here, expression, protein levels, and activity-related phosphorylation changes of MECP2 were analyzed in post-mortem human temporal cortex. The effects of wild type and phosphorylation-deficient MECP2 variants at serine 423 (S423) or S80 on microglial and neuronal function were assessed utilizing BV2 microglial monocultures and co-cultures with mouse cortical neurons under inflammatory stress conditions. MECP2 phosphorylation at the functionally relevant S423 site nominally decreased in the early stages of AD-related neurofibrillary pathology in the human temporal cortex. Overexpression of wild type MECP2 enhanced the pro-inflammatory response in BV2 cells upon treatment with lipopolysaccharide (LPS) and interferon-γ (IFNγ) and decreased BV2 cell phagocytic activity. The expression of the phosphorylation-deficient MECP2-S423A variant, but not S80A, further increased the pro-inflammatory response of BV2 cells. In neurons co-cultured with BV2 cells, the MECP2-S423A variant increased the expression of several genes, which are important for the maintenance and protection of neurons and synapses upon inflammatory stress. Collectively, functional analyses in different cellular models suggest that MECP2 may influence the inflammatory response in microglia independently of S423 and S80 phosphorylation, while the S423 phosphorylation might play a role in the activation of neuronal gene expression, which conveys neuroprotection under neuroinflammation-related stress.
    MeSH term(s) Alzheimer Disease/pathology ; Animals ; Brain/pathology ; Brain-Derived Neurotrophic Factor/metabolism ; Cell Adhesion Molecules, Neuronal/metabolism ; Coculture Techniques ; Gene Expression Regulation ; Inflammation/pathology ; Interferon-gamma ; Lipopolysaccharides ; Methyl-CpG-Binding Protein 2/metabolism ; Mice, Inbred C57BL ; Microglia/metabolism ; Microglia/pathology ; Neurons/metabolism ; Neurons/pathology ; Phagocytosis ; Phosphorylation ; Phosphoserine/metabolism ; Transcription, Genetic ; Zymosan ; Mice
    Chemical Substances Brain-Derived Neurotrophic Factor ; Cell Adhesion Molecules, Neuronal ; Lipopolysaccharides ; Methyl-CpG-Binding Protein 2 ; neuroligin 1 ; Phosphoserine (17885-08-4) ; Interferon-gamma (82115-62-6) ; Zymosan (9010-72-4)
    Language English
    Publishing date 2021-04-09
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2661518-6
    ISSN 2073-4409 ; 2073-4409
    ISSN (online) 2073-4409
    ISSN 2073-4409
    DOI 10.3390/cells10040860
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: MECP2 Increases the Pro-Inflammatory Response of Microglial Cells and Phosphorylation at Serine 423 Regulates Neuronal Gene Expression upon Neuroinflammation

    Rebekka Wittrahm / Mari Takalo / Mikael Marttinen / Teemu Kuulasmaa / Petra Mäkinen / Susanna Kemppainen / Henna Martiskainen / Tuomas Rauramaa / Ian Pike / Ville Leinonen / Teemu Natunen / Annakaisa Haapasalo / Mikko Hiltunen

    Cells, Vol 10, Iss 860, p

    2021  Volume 860

    Abstract: Methyl-CpG-binding protein 2 (MECP2) is a critical transcriptional regulator for synaptic function. Dysfunction of synapses, as well as microglia-mediated neuroinflammation, represent the earliest pathological events in Alzheimer’s disease (AD). Here, ... ...

    Abstract Methyl-CpG-binding protein 2 (MECP2) is a critical transcriptional regulator for synaptic function. Dysfunction of synapses, as well as microglia-mediated neuroinflammation, represent the earliest pathological events in Alzheimer’s disease (AD). Here, expression, protein levels, and activity-related phosphorylation changes of MECP2 were analyzed in post-mortem human temporal cortex. The effects of wild type and phosphorylation-deficient MECP2 variants at serine 423 (S423) or S80 on microglial and neuronal function were assessed utilizing BV2 microglial monocultures and co-cultures with mouse cortical neurons under inflammatory stress conditions. MECP2 phosphorylation at the functionally relevant S423 site nominally decreased in the early stages of AD-related neurofibrillary pathology in the human temporal cortex. Overexpression of wild type MECP2 enhanced the pro-inflammatory response in BV2 cells upon treatment with lipopolysaccharide (LPS) and interferon-γ (IFNγ) and decreased BV2 cell phagocytic activity. The expression of the phosphorylation-deficient MECP2-S423A variant, but not S80A, further increased the pro-inflammatory response of BV2 cells. In neurons co-cultured with BV2 cells, the MECP2-S423A variant increased the expression of several genes, which are important for the maintenance and protection of neurons and synapses upon inflammatory stress. Collectively, functional analyses in different cellular models suggest that MECP2 may influence the inflammatory response in microglia independently of S423 and S80 phosphorylation, while the S423 phosphorylation might play a role in the activation of neuronal gene expression, which conveys neuroprotection under neuroinflammation-related stress.
    Keywords Alzheimer’s disease ; MECP2 ; microglia ; neuroinflammation ; post-translational modifications ; synaptic markers ; Biology (General) ; QH301-705.5
    Subject code 571
    Language English
    Publishing date 2021-04-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: The Alzheimer's disease-associated protective Plcγ2-P522R variant promotes immune functions.

    Takalo, Mari / Wittrahm, Rebekka / Wefers, Benedikt / Parhizkar, Samira / Jokivarsi, Kimmo / Kuulasmaa, Teemu / Mäkinen, Petra / Martiskainen, Henna / Wurst, Wolfgang / Xiang, Xianyuan / Marttinen, Mikael / Poutiainen, Pekka / Haapasalo, Annakaisa / Hiltunen, Mikko / Haass, Christian

    Molecular neurodegeneration

    2020  Volume 15, Issue 1, Page(s) 52

    Abstract: Background: Microglia-specific genetic variants are enriched in several neurodegenerative diseases, including Alzheimer's disease (AD), implicating a central role for alterations of the innate immune system in the disease etiology. A rare coding variant ...

    Abstract Background: Microglia-specific genetic variants are enriched in several neurodegenerative diseases, including Alzheimer's disease (AD), implicating a central role for alterations of the innate immune system in the disease etiology. A rare coding variant in the PLCG2 gene (rs72824905, p.P522R) expressed in myeloid lineage cells was recently identified and shown to reduce the risk for AD.
    Methods: To assess the role of the protective variant in the context of immune cell functions, we generated a Plcγ2-P522R knock-in (KI) mouse model using CRISPR/Cas9 gene editing.
    Results: Functional analyses of macrophages derived from homozygous KI mice and wild type (WT) littermates revealed that the P522R variant potentiates the primary function of Plcγ2 as a Pip2-metabolizing enzyme. This was associated with improved survival and increased acute inflammatory response of the KI macrophages. Enhanced phagocytosis was observed in mouse BV2 microglia-like cells overexpressing human PLCγ2-P522R, but not in PLCγ2-WT expressing cells. Immunohistochemical analyses did not reveal changes in the number or morphology of microglia in the cortex of Plcγ2-P522R KI mice. However, the brain mRNA signature together with microglia-related PET imaging suggested enhanced microglial functions in Plcγ2-P522R KI mice.
    Conclusion: The AD-associated protective Plcγ2-P522R variant promotes protective functions associated with TREM2 signaling. Our findings provide further support for the idea that pharmacological modulation of microglia via TREM2-PLCγ2 pathway-dependent stimulation may be a novel therapeutic option for the treatment of AD.
    MeSH term(s) Alzheimer Disease/genetics ; Alzheimer Disease/immunology ; Animals ; Gene Knock-In Techniques ; Genetic Variation ; Humans ; Macrophages ; Mice ; Mice, Inbred C57BL ; Microglia/immunology ; Phospholipase C gamma/genetics ; Phospholipase C gamma/immunology
    Chemical Substances Phospholipase C gamma (EC 3.1.4.3)
    Language English
    Publishing date 2020-09-11
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1750-1326
    ISSN (online) 1750-1326
    DOI 10.1186/s13024-020-00402-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models.

    Wittrahm, Rebekka / Takalo, Mari / Kuulasmaa, Teemu / Mäkinen, Petra M / Mäkinen, Petri / Končarević, Saša / Fartzdinov, Vadim / Selzer, Stefan / Kokkola, Tarja / Antikainen, Leila / Martiskainen, Henna / Kemppainen, Susanna / Marttinen, Mikael / Jeskanen, Heli / Rostalski, Hannah / Rahunen, Eija / Kivipelto, Miia / Ngandu, Tiia / Natunen, Teemu /
    Lambert, Jean-Charles / Tanzi, Rudolph E / Kim, Doo Yeon / Rauramaa, Tuomas / Herukka, Sanna-Kaisa / Soininen, Hilkka / Laakso, Markku / Pike, Ian / Leinonen, Ville / Haapasalo, Annakaisa / Hiltunen, Mikko

    Neurobiology of disease

    2023  Volume 182, Page(s) 106140

    Abstract: The rare A673T variant was the first variant found within the amyloid precursor protein (APP) gene conferring protection against Alzheimer's disease (AD). Thereafter, different studies have discovered that the carriers of the APP A673T variant show ... ...

    Abstract The rare A673T variant was the first variant found within the amyloid precursor protein (APP) gene conferring protection against Alzheimer's disease (AD). Thereafter, different studies have discovered that the carriers of the APP A673T variant show reduced levels of amyloid beta (Aβ) in the plasma and better cognitive performance at high age. Here, we analyzed cerebrospinal fluid (CSF) and plasma of APP A673T carriers and control individuals using a mass spectrometry-based proteomics approach to identify differentially regulated targets in an unbiased manner. Furthermore, the APP A673T variant was introduced into 2D and 3D neuronal cell culture models together with the pathogenic APP Swedish and London mutations. Consequently, we now report for the first time the protective effects of the APP A673T variant against AD-related alterations in the CSF, plasma, and brain biopsy samples from the frontal cortex. The CSF levels of soluble APPβ (sAPPβ) and Aβ42 were significantly decreased on average 9-26% among three APP A673T carriers as compared to three well-matched controls not carrying the protective variant. Consistent with these CSF findings, immunohistochemical assessment of cortical biopsy samples from the same APP A673T carriers did not reveal Aβ, phospho-tau, or p62 pathologies. We identified differentially regulated targets involved in protein phosphorylation, inflammation, and mitochondrial function in the CSF and plasma samples of APP A673T carriers. Some of the identified targets showed inverse levels in AD brain tissue with respect to increased AD-associated neurofibrillary pathology. In 2D and 3D neuronal cell culture models expressing APP with the Swedish and London mutations, the introduction of the APP A673T variant resulted in lower sAPPβ levels. Concomitantly, the levels of sAPPα were increased, while decreased levels of CTFβ and Aβ42 were detected in some of these models. Our findings emphasize the important role of APP-derived peptides in the pathogenesis of AD and demonstrate the effectiveness of the protective APP A673T variant to shift APP processing towards the non-amyloidogenic pathway in vitro even in the presence of two pathogenic mutations.
    MeSH term(s) Humans ; Amyloid beta-Protein Precursor/genetics ; Amyloid beta-Protein Precursor/metabolism ; Alzheimer Disease/cerebrospinal fluid ; Amyloid beta-Peptides/metabolism ; Heterozygote ; Brain/metabolism
    Chemical Substances Amyloid beta-Protein Precursor ; Amyloid beta-Peptides
    Language English
    Publishing date 2023-04-28
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1211786-9
    ISSN 1095-953X ; 0969-9961
    ISSN (online) 1095-953X
    ISSN 0969-9961
    DOI 10.1016/j.nbd.2023.106140
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Decreased plasma C-reactive protein levels in

    Martiskainen, Henna / Takalo, Mari / Solomon, Alina / Stančáková, Alena / Marttinen, Mikael / Natunen, Teemu / Haapasalo, Annakaisa / Herukka, Sanna-Kaisa / Kuusisto, Johanna / Soininen, Hilkka / Kivipelto, Miia / Laakso, Markku / Hiltunen, Mikko

    Annals of clinical and translational neurology

    2018  Volume 5, Issue 10, Page(s) 1229–1240

    Abstract: Objective: Apolipoprotein E (: Methods: Association of cardiovascular, metabolic, and inflammation-related parameters with the : Results: Individuals carrying the : Interpretation: These data suggest that ... ...

    Abstract Objective: Apolipoprotein E (
    Methods: Association of cardiovascular, metabolic, and inflammation-related parameters with the
    Results: Individuals carrying the
    Interpretation: These data suggest that the
    Language English
    Publishing date 2018-09-17
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2740696-9
    ISSN 2328-9503
    ISSN 2328-9503
    DOI 10.1002/acn3.639
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Decreased plasma β-amyloid in the Alzheimer's disease APP A673T variant carriers.

    Martiskainen, Henna / Herukka, Sanna-Kaisa / Stančáková, Alena / Paananen, Jussi / Soininen, Hilkka / Kuusisto, Johanna / Laakso, Markku / Hiltunen, Mikko

    Annals of neurology

    2017  Volume 82, Issue 1, Page(s) 128–132

    Abstract: We investigated the association of Alzheimer's disease (AD)-related rare variants APP A673T and ABCA7 rs200538373-C with the levels of β-amyloid (Aβ) and parameters of metabolic and cardiovascular health in a population-based cohort of healthy middle- ... ...

    Abstract We investigated the association of Alzheimer's disease (AD)-related rare variants APP A673T and ABCA7 rs200538373-C with the levels of β-amyloid (Aβ) and parameters of metabolic and cardiovascular health in a population-based cohort of healthy middle-aged and elderly men. Carriers of protective APP A673T variant had, on average, 28% lower levels of Aβ40 and Aβ42 in plasma as compared to the controls and the carriers of ABCA7 rs200538373-C. This is the first report to show decreased Aβ levels in plasma in APP A673T carriers and thus provides evidence that lower Aβ levels throughout life may be protective against AD. Ann Neurol 2017;82:128-132.
    MeSH term(s) ATP-Binding Cassette Transporters/genetics ; Alzheimer Disease/blood ; Alzheimer Disease/genetics ; Amyloid beta-Peptides/blood ; Amyloid beta-Protein Precursor/genetics ; Case-Control Studies ; Heterozygote ; Humans ; Male ; Middle Aged ; Mutation ; Peptide Fragments/blood ; Protective Factors
    Chemical Substances ABCA7 protein, human ; Amyloid beta-Peptides ; Amyloid beta-Protein Precursor ; Peptide Fragments ; amyloid beta-protein (1-40) ; amyloid beta-protein (1-42)
    Language English
    Publishing date 2017-07
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80362-5
    ISSN 1531-8249 ; 0364-5134
    ISSN (online) 1531-8249
    ISSN 0364-5134
    DOI 10.1002/ana.24969
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Altered Insulin Signaling in Alzheimer's Disease Brain - Special Emphasis on PI3K-Akt Pathway.

    Gabbouj, Sami / Ryhänen, Simo / Marttinen, Mikael / Wittrahm, Rebekka / Takalo, Mari / Kemppainen, Susanna / Martiskainen, Henna / Tanila, Heikki / Haapasalo, Annakaisa / Hiltunen, Mikko / Natunen, Teemu

    Frontiers in neuroscience

    2019  Volume 13, Page(s) 629

    Abstract: Alzheimer's disease (AD) and type 2 diabetes (T2D) are both diseases with increasing prevalence in aging populations. T2D, characterized by insulin resistance and defective insulin signaling, is a common co-morbidity and a risk factor for AD, increasing ... ...

    Abstract Alzheimer's disease (AD) and type 2 diabetes (T2D) are both diseases with increasing prevalence in aging populations. T2D, characterized by insulin resistance and defective insulin signaling, is a common co-morbidity and a risk factor for AD, increasing the risk approximately two to fourfold. Insulin exerts a wide variety of effects as a growth factor as well as by regulating glucose, fatty acid, and protein metabolism. Certain lifestyle factors, physical inactivity and typical Western diet (TWD) containing high fat and high sugar are strongly associated with insulin resistance and T2D. The PI3K-Akt signaling pathway is a major mediator of effects of insulin and plays a crucial role in T2D pathogenesis. Decreased levels of phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) subunits as well as blunted Akt kinase phosphorylation have been observed in the AD brain, characterized by amyloid-β and tau pathologies. Furthermore, AD mouse models fed with TWD have shown to display altered levels of PI3K subunits. How impaired insulin-PI3K-Akt signaling in peripheral tissues or in the central nervous system (CNS) affects the development or progression of AD is currently poorly understood. Interestingly, enhancement of PI3K-Akt signaling in the CNS by intranasal insulin (IN) treatment has been shown to improve memory
    Language English
    Publishing date 2019-06-18
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2411902-7
    ISSN 1662-453X ; 1662-4548
    ISSN (online) 1662-453X
    ISSN 1662-4548
    DOI 10.3389/fnins.2019.00629
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease.

    Martiskainen, Henna / Haapasalo, Annakaisa / Kurkinen, Kaisa M A / Pihlajamäki, Jussi / Soininen, Hilkka / Hiltunen, Mikko

    Expert opinion on therapeutic targets

    2013  Volume 17, Issue 7, Page(s) 781–794

    Abstract: Introduction: Progressive neuronal loss is a key feature in Alzheimer's disease (AD), which is the most common neurodegenerative disorder in the aging population. Currently, there are no therapeutic means to intervene neuronal damage in AD and therefore ...

    Abstract Introduction: Progressive neuronal loss is a key feature in Alzheimer's disease (AD), which is the most common neurodegenerative disorder in the aging population. Currently, there are no therapeutic means to intervene neuronal damage in AD and therefore innovative approaches to discover novel strategies for the treatment of AD are needed. Based on the prevailing amyloid cascade hypothesis, it is conceivable that lowering the β-amyloid (Aβ) levels is sufficient to slow down the disease process, if started early enough.
    Areas covered: Here, we review genetic and biological functions related to apolipoprotein E (ApoE) and low-density lipoprotein receptor-related protein 1 receptor (LRP1)-mediated clearance of Aβ. Furthermore, we discuss the AD-related therapeutic potential of targeting to ApoE receptor LRP1 at the blood-brain barrier (BBB) and in the periphery.
    Expert opinion: Due to the recent setbacks in the clinical trials targeting AD, it is instrumental to seek alternative therapeutic approaches, which aim to reduce the accumulation of Aβ in the brain tissue. As the ApoE/LRP1-mediated clearance of Aβ across the BBB is the key event in the regulation of Aβ transcytosis from brain to periphery, direct targeting of this protein entity at the BBB holds a great potential in the treatment of AD.
    MeSH term(s) Alzheimer Disease/genetics ; Alzheimer Disease/metabolism ; Amyloid beta-Peptides/metabolism ; Animals ; Apolipoprotein E4/genetics ; Apolipoprotein E4/metabolism ; Humans ; Low Density Lipoprotein Receptor-Related Protein-1/genetics ; Low Density Lipoprotein Receptor-Related Protein-1/metabolism
    Chemical Substances Amyloid beta-Peptides ; Apolipoprotein E4 ; LRP1 protein, human ; Low Density Lipoprotein Receptor-Related Protein-1
    Language English
    Publishing date 2013-07
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2055208-7
    ISSN 1744-7631 ; 1472-8222
    ISSN (online) 1744-7631
    ISSN 1472-8222
    DOI 10.1517/14728222.2013.789862
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Diabetic phenotype in mouse and humans reduces the number of microglia around β-amyloid plaques.

    Natunen, Teemu / Martiskainen, Henna / Marttinen, Mikael / Gabbouj, Sami / Koivisto, Hennariikka / Kemppainen, Susanna / Kaipainen, Satu / Takalo, Mari / Svobodová, Helena / Leppänen, Luukas / Kemiläinen, Benjam / Ryhänen, Simo / Kuulasmaa, Teemu / Rahunen, Eija / Juutinen, Sisko / Mäkinen, Petra / Miettinen, Pasi / Rauramaa, Tuomas / Pihlajamäki, Jussi /
    Haapasalo, Annakaisa / Leinonen, Ville / Tanila, Heikki / Hiltunen, Mikko

    Molecular neurodegeneration

    2020  Volume 15, Issue 1, Page(s) 66

    Abstract: Background: Alzheimer's disease (AD) is the most common neurodegenerative disease and type 2 diabetes (T2D) plays an important role in conferring the risk for AD. Although AD and T2D share common features, the common molecular mechanisms underlying ... ...

    Abstract Background: Alzheimer's disease (AD) is the most common neurodegenerative disease and type 2 diabetes (T2D) plays an important role in conferring the risk for AD. Although AD and T2D share common features, the common molecular mechanisms underlying these two diseases remain elusive.
    Methods: Mice with different AD- and/or tauopathy-linked genetic backgrounds (APPswe/PS1dE9, Tau P301L and APPswe/PS1dE9/Tau P301L) were fed for 6 months with standard diet or typical Western diet (TWD). After behavioral and metabolic assessments of the mice, the effects of TWD on global gene expression as well as dystrophic neurite and microglia pathology were elucidated. Consequently, mechanistic aspects related to autophagy, cell survival, phagocytic uptake as well as Trem2/Dap12 signaling pathway, were assessed in microglia upon modulation of PI3K-Akt signaling. To evaluate whether the mouse model-derived results translate to human patients, the effects of diabetic phenotype on microglial pathology were assessed in cortical biopsies of idiopathic normal pressure hydrocephalus (iNPH) patients encompassing β-amyloid pathology.
    Results: TWD led to obesity and diabetic phenotype in all mice regardless of the genetic background. TWD also exacerbated memory and learning impairment in APPswe/PS1dE9 and Tau P301L mice. Gene co-expression network analysis revealed impaired microglial responses to AD-related pathologies in APPswe/PS1dE9 and APPswe/PS1dE9/Tau P301L mice upon TWD, pointing specifically towards aberrant microglial functionality due to altered downstream signaling of Trem2 and PI3K-Akt. Accordingly, fewer microglia, which did not show morphological changes, and increased number of dystrophic neurites around β-amyloid plaques were discovered in the hippocampus of TWD mice. Mechanistic studies in mouse microglia revealed that interference of PI3K-Akt signaling significantly decreased phagocytic uptake and proinflammatory response. Moreover, increased activity of Syk-kinase upon ligand-induced activation of Trem2/Dap12 signaling was detected. Finally, characterization of microglial pathology in cortical biopsies of iNPH patients revealed a significant decrease in the number of microglia per β-amyloid plaque in obese individuals with concomitant T2D as compared to both normal weight and obese individuals without T2D.
    Conclusions: Collectively, these results suggest that diabetic phenotype in mice and humans mechanistically associates with abnormally reduced microglial responses to β-amyloid pathology and further suggest that AD and T2D share overlapping pathomechanisms, likely involving altered immune function in the brain.
    MeSH term(s) Alzheimer Disease/metabolism ; Alzheimer Disease/pathology ; Animals ; Brain/metabolism ; Brain/pathology ; Diabetes Mellitus, Type 2/metabolism ; Diabetes Mellitus, Type 2/pathology ; Humans ; Mice ; Microglia/metabolism ; Microglia/pathology ; Phenotype ; Plaque, Amyloid/pathology
    Language English
    Publishing date 2020-11-10
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1750-1326
    ISSN (online) 1750-1326
    DOI 10.1186/s13024-020-00415-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top